I would like to see one more. A 1 for 20 right now would be nice. That is if they are working with major exchange for rapid uplisting. Otherwise, it wouldn't make sense.
biotech-researcher, I sure hope not. Never ends up well for the small investors ,like me. I suffered through the second one and I don't even want to think about suffering through another one. I would be devastated and sue the company if they did it without shareholder consent. Do they need shareholder consent? Peace Reg 2015